Moneycontrol PRO
you are here: HomeNewsIndia

Surge not so worrying if serious cases, deaths are low: Experts

They are also of the view that the new cases being reported daily should be categorised as mild, moderate or severe to better understand the pandemic.

August 31, 2020 / 10:13 AM IST

The rise in number of COVID-19 cases should not be a cause of concern as long as the number of serious patients and deaths due to the disease remain low, say public health experts in Gujarat.

They are also of the view that the new cases being reported daily should be categorised as mild, moderate or severe to better understand the pandemic.

"We are finding new cases everyday, but the first thing we need to know is how many of them are serious," said Dileep Mavalankar, Director of the Gandhinagar-based Indian Institute of Public Health.

"The government should report how many new patients have been put on oxygen or ventilator support...we are reporting low mortality," he said.

The new cases should be divided into three categories- mild, moderate, if a patient needs oxygen, and severe, if he/she needs ventilator support, he said.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more

In a recent study, Mavalankar found that between March and July, the percentage of deaths due to COVID-19 compared to other diseases in India was 1.3, as against 13 per cent in the US and 17.6 per cent in the UK.

He said the government should not neglect fatalities due to other reasons just to control the over one per cent COVID-19 deaths.

At the same time, the government should provide more data in the public domain for experts to understand the pandemic situation better, he said.

The data should include the nature of new daily cases, as to how many of them are mild, moderate or severe. The government should also provide data separately on the number of suspected COVID-19 cases and the cases being reported in urban and rural areas, Mavalankar said.

"The disease will, of course, spread. Even high profile people are getting the disease. We need to focus on reducing the number of deaths. In terms of data, we need to ask the government to separate mild cases from moderate and severe," he said.

In Gujarat, Surat city has reported the highest number of new COVID-19 cases in recent times.

"But, that alone should not concern us as only about 400 patients are hospitalised, and the rest, around 500, are in home isolation, taken care of by a dedicated team of doctors," Surat Municipal Commissioner B N Pani said.

There is a perception that the situation is quite bad because of the number of cases being very high. But a look at the bed occupancy shows the number of people in hospitals is very low, he said.

"There are currently 872 active COVID-19 cases in Surat, out of whom 400 patients are hospitalised. Plasma therapy and medicines like Ramdesivir have helped treat severe cases and reduce the number of deaths. Early detection is also reducing the mortality," he said.

Pani said the COVID-19 death rate has come down in Surat and the severity of cases has also considerably decreased.

He claimed Surat has achieved the highest number of plasma donations and use of plasma therapy in the entire country. So far, around 994 patients here have been given the plasma therapy, he added.

Also, the civic body has formed a task force for the diamond and textiles industries and issued standard operating procedures for them.

Till Sunday, Surat reported 20,855 COVID-19 cases and 809 deaths due to the disease. The state has so far reported 95,155 cases and 3,008 deaths, as per the health department.

Gujarat COVID-19 task force member Dr Tushar Patel said though more new cases of the disease are being reported every day, a large number of patients are asymptomatic or mildly symptomatic.

"Hence, the situation is not worrying as such patients get treated with home isolation," he said.

"There are active cases, but the number of critically ill patients has gone down, as we can see empty beds in ICUs of dedicated COVID-19 hospitals. Active cases will remain, but at the same time the positivity rate has come down," he said.

Three months ago, reports of eight out of 10 people tested used to come out positive for COVID-19. Now only about two out of 10 come out positive, said Dr Patel, who is a pulmonologist.

first published: Aug 31, 2020 09:24 am